Becton Dickinson said this week that the US Food and Drug Administration has cleared its BD Max Group B Streptococcus Assay for detecting GBS DNA in Lim broth cultures.

BD said that the PCR-based in vitro diagnostic test runs on its second-generation BD Max System, and received CLIA moderate complexity test categorization.

The firm is also developing methicillin-resistant Staphylococcus aureus and Clostridium difficile assays to run on the BD Max system.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.